Subscribe
brexit_istock-531915594_altamira83
altamira83 / iStockphoto.com
23 July 2018Big Pharma

Parliament votes for UK to stay in EMA

The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency (EMA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Brexit plan reassuring for pharma industry, but uncertainties remain: lawyers
16 July 2018   While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.
Big Pharma
EMA scales back activities ahead of Brexit
2 August 2018   The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.
Big Pharma
UK shares Brexit implementation plans for life sciences
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Big Pharma
Brexit plan reassuring for pharma industry, but uncertainties remain: lawyers
16 July 2018   While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.
Big Pharma
EMA scales back activities ahead of Brexit
2 August 2018   The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.
Big Pharma
UK shares Brexit implementation plans for life sciences
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.

More on this story

Big Pharma
Brexit plan reassuring for pharma industry, but uncertainties remain: lawyers
16 July 2018   While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.
Big Pharma
EMA scales back activities ahead of Brexit
2 August 2018   The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.
Big Pharma
UK shares Brexit implementation plans for life sciences
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers